Mahalo | $2,600,000 | (Jun 26, 2025)
Elfie | $12,000,000 | (Jun 26, 2025)
AllSpice.io | $15,000,000 | (Jun 26, 2025)
Certified by Founder
Lodge
eGenesis, Inc.
start up
United States
- Cambridge, MA
- 04/09/2024
- Series B
- $191,000,000
eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis’ mission is to solve the global organ shortage crisis by developing a scalable alternative to allotransplantation.
eGenesis is reinvigorating the field of xenotransplantation by addressing the key virology and immunology hurdles that have prevented its advancement to date, and is developing commercially-viable products to save and improve the lives of patients who are waiting for an organ transplant.
- Industry Biotechnology Research
- Website https://egenesisbio.com/
- LinkedIn https://www.linkedin.com/company/egenesisbio/
Pro Athlete Community (PAC) | $7,600,000 | (Jun 26, 2025)
Kalshi | $185,000,000 | (Jun 26, 2025)
Armory | $1,511,654 | (Jun 26, 2025)
Obviant | $7,100,000 | (Jun 26, 2025)
Qunnect | $10,000,000 | (Jun 26, 2025)
Neuron23 | $96,500,000 | (Jun 26, 2025)
Digital Asset | $135,000,000 | (Jun 25, 2025)
Waltz | $50,000,000 | (Jun 25, 2025)
Blank Metal | $3,000,000 | (Jun 25, 2025)